StockData
Profound Medical Corp. logo

Profound Medical Corp. (PROF) stock

PROFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$7.85+0.17 (+2.21%)

Close on Nov 11, 2026Market cap $286.78MP/E –Yield –

Profound Medical total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Profound Medical's total debt was $4.51M at Sep 30, 2026. For fiscal 2025 it was $4.50M, down 3.5% from the year before. The highest annual figure on record is $9.14M in fiscal 2019.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.50M-3.5%
FY2024Dec 31, 2024$4.66M-34.4%
FY2023Dec 31, 2023$7.10M-1.0%
FY2022Dec 31, 2022$7.17M-21.5%
FY2019Dec 31, 2019$9.14M+4.2%
FY2018Jan 1, 2019$8.76M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$4.51M+0.7%
Q2 FY2026Jun 30, 2026$4.51M+1.0%
Q1 FY2026Mar 31, 2026$4.50M+0.4%
Q4 FY2025Dec 31, 2025$4.50M-3.5%
Q3 FY2025Sep 30, 2025$4.48M-36.9%
Q2 FY2025Jun 30, 2025$4.46M-37.8%
Q1 FY2025Mar 31, 2025$4.49M-50.9%
Q4 FY2024Dec 31, 2024$4.66M-46.8%
Q4 FY2023Dec 31, 2023$7.10M–
Q4 FY2022Dec 31, 2022$7.17M–
Q4 FY2019Dec 31, 2019$9.14M–
Q4 FY2018Jan 1, 2019$8.76M–

More Profound Medical figures

See a number that looks wrong?